K50.114 describes a specific manifestation of Crohn's disease localized to the large intestine (colon), characterized by the presence of rectal bleeding. Crohn's disease is a chronic, transmural inflammatory condition of the gastrointestinal tract. When it involves the large intestine, it is often referred to as Crohn's colitis. The complication of rectal bleeding (hematochezia) occurs when deep, penetrating ulcerations erode into mucosal or submucosal blood vessels. This manifestation requires careful clinical management to differentiate it from other causes of lower gastrointestinal bleeding, such as ulcerative colitis or diverticular disease, and to monitor for secondary complications like iron-deficiency anemia.
Explicitly identify the location of Crohn's disease as the large intestine to support K50.1 subcategory specificity.
Example: Patient with established Crohn's disease of the large intestine, specifically involving the descending colon and sigmoid. Patient presents with bright red rectal bleeding during this flare. Plan includes escalation of biologic therapy for moderate-to-severe disease activity. Chronic condition management for Crohn's remains active and impacts clinical decision-making regarding potential surgical intervention.
Billing Focus: Documentation must specify the large intestine as the anatomical site to differentiate from small bowel or ileocolic involvement.
Document the presence of rectal bleeding as a direct complication of the Crohn's disease to justify the K50.114 code.
Example: Assessment: Crohn's disease of the large intestine with rectal bleeding. Patient reports 4-5 bloody bowel movements daily. Hemoglobin stable at 11.2, but trended down from 12.5 last month. Bleeding is attributed to active colonic inflammation rather than hemorrhoidal disease. This complication requires urgent corticosteroid induction therapy.
Billing Focus: The link between the primary diagnosis and the complication (rectal bleeding) must be clear in the assessment and plan.
Differentiate between rectal bleeding and other complications like fistulae or abscesses when multiple issues are present.
Example: 65-year-old female with Crohn's disease of the large intestine presenting with active rectal bleeding. No evidence of perianal fistula or intra-abdominal abscess on physical exam or recent imaging. Condition is considered an acute flare of chronic colonic Crohn's. Management involves monitoring for anemia and adjusting Vedolizumab dosing.
Billing Focus: Identifying the specific complication prevents code bundling and ensures the highest level of specificity (K50.114 vs K50.119).
Specify the severity of the rectal bleeding and its impact on the patient's systemic status.
Example: Diagnosis: Chronic Crohn's disease of the large intestine, currently flaring with significant rectal bleeding and associated iron deficiency anemia. Patient is tachycardic but hemodynamically stable. Rectal bleeding is persistent throughout the day. Plan includes intravenous iron sucrose and high-dose oral Prednisone.
Billing Focus: Associated symptoms like anemia should be coded separately to provide a full clinical picture and support higher-level E/M coding.
Always document the current status of the disease, such as in relapse or flaring, alongside the bleeding complication.
Example: Patient with Crohn's disease of the large intestine, in relapse with rectal bleeding. Previous colonoscopy showed severe ulceration in the transverse colon. Current symptoms include tenesmus and hematochezia. Risk of progression to toxic megacolon is monitored. Biologic therapy failure suspected; anti-TNF levels ordered.
Billing Focus: Using terms like in relapse or flaring helps justify medical necessity for high-intensity diagnostic or therapeutic procedures.
Typically used for management of chronic conditions with complications or flares, such as Crohn's with bleeding.
Appropriate for severe flares involving complications like significant rectal bleeding or potential surgical necessity.
Essential for evaluating the extent of colonic inflammation and identifying the source of rectal bleeding.
Used to obtain tissue samples to confirm the diagnosis of Crohn's and rule out other causes of colitis.
May be used for tattooing to mark specific sites for future surgical resection or to inject medications.
Initial consultation for a patient presenting with newly diagnosed or complex Crohn's with complications.
Surgical intervention required when medical therapy fails to control colonic Crohn's or its complications.
Biologic therapy commonly used to induce and maintain remission in moderate-to-severe colonic Crohn's.
Used for the administration of biologics like Infliximab in the office setting.
Used for routine follow-up of stable Crohn's disease where minimal medication changes are needed.